Congress
For more information concerning work and views related to Congress, please contact our office.
More on Congress
Republican Texas Rep. Morgan Luttrell locked horns with a legal expert Wednesday over Department of Homeland Security (DHS) Secretary Alejandro Mayorkas’ role in the fentanyl crisis.
WASHINGTON — Texas Republicans on the U.S. House Homeland Security Committee excoriated Homeland Security Secretary Alejandro Mayorkas during a hearing Wednesday as conservatives seek to impeach the secretary over the rise in illegal crossings on the southern border.
WASHINGTON – Congressman Morgan Luttrell (R-TX) and his Republican colleagues on the House Armed Services Committee (HASC) sent a letter to Secretary of Defense Lloyd J.
WASHINGTON – Congressman Morgan Luttrell (R-TX) applauded the Department of Veterans Affairs’ decision to request applications for proposals to research the use of psychedelic therapies to treat post-traumatic stress disorder (PTSD), traumatic brain injuries (TBI), and other combat-related injuries.
WASHINGTON – Congressman Morgan Luttrell (R-TX), along with Congresswomen Mariannette Miller-Meeks (R-IA), Elissa Slotkin (D-MI), and Rob Menendez (D-NJ), introduced the Customs-Trade Partnership Against Terrorism (CTPAT) Pilot Program Act.
WASHINGTON — Tucked within Congress’ colossal annual defense bill is a priority a vocal group of Texas conservatives has long pushed: Using psychedelics to treat post-traumatic stress disorder.
WASHINGTON -- Congressman Morgan Luttrell (R-TX) scored several key wins in the Fiscal Year 2024 (FY24) National Defense Authorization Act (NDAA), which was adopted in the House and Senate and now heads to the President’s desk to be signed into law. As a member of the House Armed Services Committee and conferee to the NDAA Conference Committee, Rep.
WASHINGTON — Sixty percent of veterans who die from suicide each year had no recent engagement with health care services at the Department of Veterans Affairs.
Lawmakers frustrated with federal officials’ lack of progress in preventing veterans suicides suggested on Tuesday that more of the $16 billion allotted for those outreach efforts be given to
Congress is on track to approve legislation that would mark a significant advance in U.S. policy toward psychedelics.
Tucked into the National Defense Authorization Act of 2024 is a provision to fund clinical trials using psychedelic substances to treat active duty members of the military.